Geetha Subramaniam Selected Research

N-nitrosoiminodiacetic acid

1/2022	The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations.
1/2013	Common data elements for substance use disorders in electronic health records: the NIDA Clinical Trials Network experience.
1/2013	Blending research and practice: an evolving dissemination strategy in substance abuse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geetha Subramaniam Research Topics

Disease

7	Substance-Related Disorders (Drug Abuse) 01/2022 - 03/2010
6	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 11/2008
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2011
1	Pain (Aches) 03/2010
1	Myocardial Infarction 01/2005
1	Necrosis 01/2005

Drug/Important Bio-Agent (IBA)

3	N-nitrosoiminodiacetic acidIBA 01/2022 - 01/2013
3	Opioid Analgesics (Opioids)IBA 01/2018 - 03/2010
2	Naloxone Drug Combination Buprenorphine FDA Link 01/2016 - 03/2010
2	Buprenorphine (Subutex)FDA LinkGeneric 01/2016 - 11/2008
1	trans-crotonin (CTN)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Pharmaceutical PreparationsIBA 09/2011
1	Methylphenidate (Ritalin)FDA LinkGeneric 09/2011
1	Naltrexone (ReVia)FDA LinkGeneric 09/2010
1	Cocaine (Cocaine HCl)IBA 03/2010
1	Nicotine FDA Link 03/2010
1	C-Reactive ProteinIBA 01/2005

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2010